Salo E, Kekomäki R, Pelkonen P, Ruuskanen O, Viander M, Wagner O
Children's Hospital, University of Helsinki, Finland.
Eur J Pediatr. 1988 May;147(4):377-80. doi: 10.1007/BF00496414.
We followed the levels of circulating immune complexes (CIC) in 27 patients with Kawasaki disease (KD) from the acute stage of the disease through convalescence, using the test for platelet-reactive IgG-IC, and C1q-binding and conglutinin-binding enzyme immunoassays. CIC were detected by one or more techniques in all but one patient. Positive results were obtained most often with the test for platelet-reactive IgG-IC. Measurement of complement components C3 and C4 in 14 patients revealed an increase in C3 levels during the first few weeks of the disease and normal levels of C4. The blood platelet count correlated directly with the level of platelet-reactive IgG-IC. The highest levels of CIC were found during weeks 3 through 7 after the onset of disease. Measurement of CIC is, however, not applicable to the clinical follow-up of patients with KD.
我们采用血小板反应性IgG-IC检测以及C1q结合和胶固素结合酶免疫测定法,对27例川崎病(KD)患者从疾病急性期至恢复期的循环免疫复合物(CIC)水平进行了跟踪监测。除1例患者外,所有患者均通过一种或多种技术检测到CIC。血小板反应性IgG-IC检测最常获得阳性结果。对14例患者的补体成分C3和C4进行测量发现,疾病最初几周C3水平升高,C4水平正常。血小板计数与血小板反应性IgG-IC水平直接相关。疾病发作后第3至7周CIC水平最高。然而,CIC检测不适用于KD患者的临床随访。